COVID-19

Views & Analysis

Coronavirus pharma news roundup 15/5/20

This week saw some mixed news in coronavirus research as questions were raised about access to COVID-19 drugs as studies – and approvals – continued apace.

News

Sanofi CEO courts controversy after saying US is first in li...

Sanofi’s CEO Paul Hudson has courted controversy by saying the French pharma’s potential COVID-19 vaccine will likely be delivered to the US government first should it succeed in clinical t

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

R&D

COVID-19 May Briefing: The UK&I Healthcare Ecosystem Fightba...

The third webinar* in the COVID-19 monthly briefing series was designed to provide insight from life sciences thought-leaders and to generate discussion on issues that pharma and biotech co

Views & Analysis

COVID-19 and vulnerable children: Urging caution while enjoy...

How do you keep a child with a suppressed immune system safe during COVID-19 lockdown? And how do you explain the dangers while protecting their – and your own – mental health?

Partner Content